Navigation Links
Clinical Innovations Introduces New Circumcision Device
Date:6/11/2009

SALT LAKE CITY, June 11 /PRNewswire/ -- Clinical Innovations has launched its new disposable circumcision device, the AccuCirc, to help clinicians provide precise, consistent and reliable circumcision outcomes. Touted as the only significant innovation in circumcision of the past 50 years, the AccuCirc utilizes revolutionary technology to protect the glans, ensure adequate hemostasis, and deliver the precise cut of the foreskin in a single actuation.

The AccuCirc uses two innovative components to complete the circumcision procedure: the Foreskin Probe/Shielding Ring and the Single-Action Clamp. The Foreskin Probe/Shielding Ring ensures that the glans is protected and the foreskin is properly aligned, while the Single-Action Clamp ensures adequate hemostasis and the precise delivery of the protected, circular blade.

"These two components work together to protect the infant from injury," said Dr. David Tomlinson, a Family Medicine Practitioner in Rhode Island and primary inventor. "Not only do they simplify the circumcision procedure, but they also eliminate the need for a dorsal slit and remove the potential for mismatching parts. They also do away with the use of freehand scalpels, scissors, reusable clamps and safety pins in the procedure."

The FDA issued a warning in 2000 for potential injury from the use of mismatched sizes and parts of traditional circumcision clamps, stating its concern over serious device-related complications. "We designed the AccuCirc to eliminate complications that typically come from mismatched parts or freehand cutting," said Wm. Dean Wallace, MD, PhD, and Executive Vice-President of Research and Development. "The Shielding Ring shields the glans from ever touching the blade and the Foreskin Probe acts as a key that activates the crushing arms and blade only when the correct size is placed within the device."

The AccuCirc comes in a self-contained circumcision kit; including the foreskin probe/shielding ring, single-action clamp and blade, fenestrated drape with adhesive backing, surgical marking pen, hemostats, sanitizing wipe, iodine swab sticks, lubricating jelly, petrolatum dressing, and gauze. The kit is completely disposable and no part of the device is retained on the infant.

The AccuCirc is sold through independent distributors around the United States. Visit www.accucirc.com for more information, or contact us directly at:

    Clinical Innovations
    747 West 4170 South
    Murray, UT 84123
    Tel. 801-268-8200
    Fax 801-266-7373
    Website: www.accucirc.com
    Email: accucirc@clinicalinnovations.com

About Clinical Innovations

Clinical Innovations develops, manufactures and markets state-of-the-art medical devices with particular emphasis on improving outcomes for women and their infants (www.clinicalinnovations.com).


'/>"/>
SOURCE Clinical Innovations
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... Ten outstanding teachers in the Greater Houston area ... will win a visit by a Houston Texans player, two tickets to a Texans ... years old can visit texanschecking.com/stars to nominate their favorite teacher with an essay of ...
(Date:8/16/2017)... Georgia (PRWEB) , ... August 16, 2017 , ... ... in Atlanta, opened their doors. They celebrate 30 years in business this year, ... create an up-to-date, inviting, tranquil space to serve their patients. , It ...
(Date:8/16/2017)... ... August 16, 2017 , ... Maury Regional Health has announced ... draws. By broadly deploying AccuVein devices, Maury Regional Medical Center is making vein visualization ... out of a needle stick and more importantly, helps our staff members locate a ...
(Date:8/16/2017)... ... 2017 , ... A global leader in the treatment of clubfoot, CURE ... Indian states—bringing the country one step closer to eliminating clubfoot as a lifelong disability ... on track to enroll 10,000 children in the clubfoot treatment program in this year ...
(Date:8/16/2017)... ... ... Fusion Flix Inc., a Telly Award Winning, Non Profit Corporation has announced their ... a partnership with the Amazon Video Direct Streaming Distribution Platform. , Their content will ... in 2018. Proceeds will be going to further health research. , Fusion Flix ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... -- Axium Pharmaceuticals Inc., the creator of the drug Truveta for ... of an IPO. The United States ... of a prescription epilepsy drug being $450.00-$1200.00 for a one month supply. ... AXIUM PHARMACEUTICALS, INC ... staggering figure is the fact that Americans spent $42 billion on anxiety ...
(Date:8/14/2017)... Israel , Aug. 15, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced financial ... "We are in ... 3 trial to investigate NurOwn ® in ALS," ... Officer of BrainStorm. "We have agreements with Mass. General ...
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
Breaking Medicine Technology: